Athira Pharma Reports First Quarter 2024 Financial Results and Pipeline and Business Updates
May 15, 2024 16:05 ET
|
Athira Pharma, Inc.
Athira Pharma Reports First Quarter 2024 Financial Results and Pipeline and Business Updates
Acumen Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Highlights
May 14, 2024 07:00 ET
|
Acumen Pharmaceuticals, Inc.
Announced initiation of ALTITUDE-AD, a Phase 2 study to investigate sabirnetug (ACU193) for the treatment of early Alzheimer’s disease, in May 2024Initiation of a Phase 1 study to support a...
Fennec Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
May 14, 2024 06:03 ET
|
Fennec Pharmaceuticals Inc.
~ Achieved First Quarter 2024 Total Net Revenues of $25.4 Million, Including $18.0 Million in Licensing Revenue from Recently Announced Norgine Transaction ~ ~ Executed Exclusive Licensing Agreement...
VITAS® Healthcare Names Four Leaders to Its Executive Team: Melad, Escueta, Dr. Loftis, Durkin
May 13, 2024 07:42 ET
|
VITAS Healthcare
Following several recent promotions announced by the national hospice provider, four new leaders join VITAS Healthcare's executive team.
Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2024 Financial Results
May 13, 2024 07:00 ET
|
Praxis Precision Medicines, Inc.
Plans to initiate two efficacy studies investigating PRAX-628 in focal onset seizures in the second half of 2024 and first half of 2025, respectively Continued strong recruitment for the pivotal...
Merkel Cell Carcinoma Treatment Market To Reach USD 4.3 Billion By 2032 | DataHorizzon Research
May 11, 2024 03:40 ET
|
DataHorizzon Research
Fort Collins, Colorado, May 11, 2024 (GLOBE NEWSWIRE) -- The rise in skin disorders aggravates the need for merkel cell carcinoma treatment industry. The merkel cell carcinoma treatment market is...
Four Independent Scientific Abstracts at the American Academy of Dental Sleep Medicine Annual Meeting Feature ProSomnus Intraoral Medical Devices
May 09, 2024 18:30 ET
|
ProSomnus Sleep Technologies, Inc.
Four Independent Scientific Abstracts at the American Academy of Dental Sleep Medicine Annual Meeting Feature ProSomnus Intraoral Medical Devices
Sensus Healthcare Reports First Quarter 2024 Financial Results With Revenues up More than Three-fold
May 09, 2024 16:05 ET
|
Sensus Healthcare, Inc.
Revenues of $10.7 million, compared with $3.4 million in the prior-year quarter; Adjusted EBITDA (a non-GAAP measure) of $3.0 million, compared with negative $2.7 million in the prior-year...
Collegium Reports First Quarter 2024 Financial Results
May 09, 2024 16:02 ET
|
Collegium Pharmaceutical, Inc.
– Generated Q1’24 Net Revenue of $144.9 Million – – Delivered Q1’24 Record Belbuca® Revenue of $50.7 Million; Total Prescriptions Up 4.2% Year-over-Year – – Achieved Q1’24 GAAP Net...
Allakos Provides Business Update and Reports First Quarter 2024 Financial Results
May 09, 2024 16:02 ET
|
Allakos Inc.
SAN CARLOS, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company developing antibodies for the treatment of allergic, inflammatory and...